JP Matthews
23 works · 1,671 citations · h-index 13
Top works
- A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]
- Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group
- Clinical factors influencing the efficacy of pooled platelet transfusions
- A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.
- Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir
- Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
- Surgery in acute leukemia: A review of 167 operations in thrombocytopenic patients
- The definition of refractoriness to platelet transfusions
- A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation
- Rapid screening for depression – validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients
- MANTLE IRRADIATION FOR STAGE I AND STAGE II HODGKIN'S DISEASE – RESULTS OF A 10 YEAR EXPERIENCE
- A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma
- Failure of intensive chemotherapy in poor prognosis non‐Hodgkin's lymphoma
- Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study
- A Phase I/II Study of Intensive Dose Escalation of Cytarabine in Combination with Idarubicin and Etoposide in Induction and Consolidation Treatment of Adult Acute Myeloid Leukemia
- Dose-intensification does not improve outcome in aggressive non-Hodgkin's lymphoma (NHL). Report of a randomized trial by the Australasian Leukemia and Lymphoma Group (ALLG).
- Increased survival in patients diagnosed with Hodgkin's disease in Tasmania, 1972–1992
- Idarubicin, cytarabine in standard or high-dose, and etoposide ± lenograstim (G-CSF). Combinations giving high remission rates in acute myeloid leukaemia.
- Idarubicin, cytarabine in standard or high-dose, and etoposide ± lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates.
- The treatment of low grade non-Hodgkin's lymphoma in elderly people.